Industry: Chemical & Material
Published Date: 2025-07-27
Pages: 148 Pages
Report ld: 4801480
Request Sample
Customized Report
Salmon PDRN API Market Size(US$)

CAGR 2025-2031
32.5%
Market Size,2031
USD 540
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Salmon PDRN API was estimated to be worth US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Salmon PDRN API cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
PDRN is deoxyribonucleic acid(DNA) product, mainly comes from semen and roe of fish, rapidly repair injured scars. It can promote the collagen synthesis on the cell surface, reverse aging signs. PDRN is the excellent skin repair product widely used for both high-end beauty products and medical products. Strong functions of anti-radiation and shrinking pores, make skin appears brightly and elastically.
Polydeoxyribonucleotide (PDRN) and polynucleotide (PN) are regenerative materials extracted from the regenerative cell (sperm and testicle) gene segment (DNA) of salmon or trout. The molecular sizes of PDRN and PN are different (PN is bigger) and they are safe biogenic substances approved by the Ministry of Food and Drug Safety. PDRN are often used in pharmaceuticals for tissue regeneration and cornea regeneration as well as treatment and tissue restoration of wounds. PN is often used for medical devices (tissue regeneration) for skin regeneration, articular cartilage regeneration, and osteogenic tissues.
Both PDRN and PN are included in the report.
As a product of regenerative medicine, PDRN can synthesize DNA from damaged or hypoxic tissues, activate the regeneration of endogenous growth factors such as FGF, IGF, and EGF, accelerate cell metabolism, and improve skin repair and regeneration capabilities. The fiber network full of collagen and elastin can achieve skin rejuvenation, improve skin microenvironment, increase skin thickness, etc., so as to achieve the effect of improving problem skin.
The PDRN market has shown a significant growth trend in recent years, mainly driven by the field of regenerative medicine and tissue engineering, as well as the field of aesthetics. Demand for innovative solutions in medical fields such as wound healing, dermatology, orthopedics is driving the demand for PDRN products and therapies.
In terms of product types, freeze-dried powder occupies an important position, dominated with 65% market share in 2024, preferred for stability and versatility in pharmaceuticals and cosmetics. While PDRN Solutions are growing demand in injectables (e.g., mesotherapy), especially in Korea’s "salmon needle" treatments. Expected to surge due to ease of clinical applicationAt the same time, in terms of application, the share of Medical Aesthetics (Mesotherapy) in 2024 is about 32%, used in "regenerative hydrogels" for collagen synthesis and anti-inflammatory effects.
The major global manufacturers of Salmon PDRN API include HTL Biotechnology, Ruijiming Biological, PharmaResearch Co., Ltd., Humedix, ReaLi Tide Biological, HENGYU BIOPH, Mastelli, Dongkook, BR PHARM, BMI KOREA, BNF Solution, etc. In 2024, the world's top three vendors accounted for approximately 56% of the revenue.
As a new type of regenerative material, PDRN has multiple activities such as promoting skin damage repair, anti-inflammatory, promoting angiogenesis, improving tissue microcirculation, etc. It has broad application prospects in the fields of medical devices, medicine, cosmetics, health foods, daily chemical products, medical cosmetology, etc. In the future, with the rise of medical beauty consumption and the expansion of application fields, the scale of the PDRN market will further expand. The PDRN market is poised for explosive growth, anchored by Asia-Pacific’s dominance (Korea/China) and diversification into cosmetics/wound care. Key developments include China’s regulatory openings, plant-based innovations, and the rise of "regenerative aesthetics."
This report aims to provide a comprehensive presentation of the global market for Salmon PDRN API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Salmon PDRN API by region & country, by Type, and by Application.
The Salmon PDRN API market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Salmon PDRN API.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Salmon PDRN API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Salmon PDRN API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Salmon PDRN API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Salmon PDRN API Product Introduction
1.2 Global Salmon PDRN API Market Size Forecast
1.2.1 Global Salmon PDRN API Sales Value (2020-2031)
1.2.2 Global Salmon PDRN API Sales Volume (2020-2031)
1.2.3 Global Salmon PDRN API Sales Price (2020-2031)
1.3 Salmon PDRN API Market Trends & Drivers
1.3.1 Salmon PDRN API Industry Trends
1.3.2 Salmon PDRN API Market Drivers & Opportunity
1.3.3 Salmon PDRN API Market Challenges
1.3.4 Salmon PDRN API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Salmon PDRN API Players Revenue Ranking (2024)
2.2 Global Salmon PDRN API Revenue by Company (2020-2025)
2.3 Global Salmon PDRN API Players Sales Volume Ranking (2024)
2.4 Global Salmon PDRN API Sales Volume by Company Players (2020-2025)
2.5 Global Salmon PDRN API Average Price by Company (2020-2025)
2.6 Key Manufacturers Salmon PDRN API Manufacturing Base and Headquarters
2.7 Key Manufacturers Salmon PDRN API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Salmon PDRN API
2.9 Salmon PDRN API Market Competitive Analysis
2.9.1 Salmon PDRN API Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Salmon PDRN API Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Salmon PDRN API as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Powder
3.1.2 Solution
3.2 Global Salmon PDRN API Sales Value by Type
3.2.1 Global Salmon PDRN API Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Salmon PDRN API Sales Value, by Type (2020-2031)
3.2.3 Global Salmon PDRN API Sales Value, by Type (%) (2020-2031)
3.3 Global Salmon PDRN API Sales Volume by Type
3.3.1 Global Salmon PDRN API Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Salmon PDRN API Sales Volume, by Type (2020-2031)
3.3.3 Global Salmon PDRN API Sales Volume, by Type (%) (2020-2031)
3.4 Global Salmon PDRN API Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Mesotherapy
4.1.2 Bone Injection & Dermal Fillers
4.1.3 Pharmaceutical
4.1.4 Cosmetic
4.1.5 Wound Healing Products and Others
4.2 Global Salmon PDRN API Sales Value by Application
4.2.1 Global Salmon PDRN API Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Salmon PDRN API Sales Value, by Application (2020-2031)
4.2.3 Global Salmon PDRN API Sales Value, by Application (%) (2020-2031)
4.3 Global Salmon PDRN API Sales Volume by Application
4.3.1 Global Salmon PDRN API Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Salmon PDRN API Sales Volume, by Application (2020-2031)
4.3.3 Global Salmon PDRN API Sales Volume, by Application (%) (2020-2031)
4.4 Global Salmon PDRN API Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Salmon PDRN API Sales Value by Region
5.1.1 Global Salmon PDRN API Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Salmon PDRN API Sales Value by Region (2020-2025)
5.1.3 Global Salmon PDRN API Sales Value by Region (2026-2031)
5.1.4 Global Salmon PDRN API Sales Value by Region (%), (2020-2031)
5.2 Global Salmon PDRN API Sales Volume by Region
5.2.1 Global Salmon PDRN API Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Salmon PDRN API Sales Volume by Region (2020-2025)
5.2.3 Global Salmon PDRN API Sales Volume by Region (2026-2031)
5.2.4 Global Salmon PDRN API Sales Volume by Region (%), (2020-2031)
5.3 Global Salmon PDRN API Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Salmon PDRN API Sales Value, 2020-2031
5.4.2 North America Salmon PDRN API Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Salmon PDRN API Sales Value, 2020-2031
5.5.2 Europe Salmon PDRN API Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Salmon PDRN API Sales Value, 2020-2031
5.6.2 Asia Pacific Salmon PDRN API Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Salmon PDRN API Sales Value, 2020-2031
5.7.2 South America Salmon PDRN API Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Salmon PDRN API Sales Value, 2020-2031
5.8.2 Middle East & Africa Salmon PDRN API Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Salmon PDRN API Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Salmon PDRN API Sales Value and Sales Volume
6.2.1 Key Countries/Regions Salmon PDRN API Sales Value, 2020-2031
6.2.2 Key Countries/Regions Salmon PDRN API Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Salmon PDRN API Sales Value, 2020-2031
6.3.2 United States Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Salmon PDRN API Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Salmon PDRN API Sales Value, 2020-2031
6.4.2 Europe Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Salmon PDRN API Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Salmon PDRN API Sales Value, 2020-2031
6.5.2 China Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.5.3 China Salmon PDRN API Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Salmon PDRN API Sales Value, 2020-2031
6.6.2 Japan Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Salmon PDRN API Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Salmon PDRN API Sales Value, 2020-2031
6.7.2 South Korea Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Salmon PDRN API Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Salmon PDRN API Sales Value, 2020-2031
6.8.2 Southeast Asia Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Salmon PDRN API Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Salmon PDRN API Sales Value, 2020-2031
6.9.2 India Salmon PDRN API Sales Value by Type (%), 2024 VS 2031
6.9.3 India Salmon PDRN API Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 HTL Biotechnology
7.1.1 HTL Biotechnology Company Information
7.1.2 HTL Biotechnology Introduction and Business Overview
7.1.3 HTL Biotechnology Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 HTL Biotechnology Salmon PDRN API Product Offerings
7.1.5 HTL Biotechnology Recent Development
7.2 ReaLi Tide Biological
7.2.1 ReaLi Tide Biological Company Information
7.2.2 ReaLi Tide Biological Introduction and Business Overview
7.2.3 ReaLi Tide Biological Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 ReaLi Tide Biological Salmon PDRN API Product Offerings
7.2.5 ReaLi Tide Biological Recent Development
7.3 PharmaResearch Co., Ltd.
7.3.1 PharmaResearch Co., Ltd. Company Information
7.3.2 PharmaResearch Co., Ltd. Introduction and Business Overview
7.3.3 PharmaResearch Co., Ltd. Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 PharmaResearch Co., Ltd. Salmon PDRN API Product Offerings
7.3.5 PharmaResearch Co., Ltd. Recent Development
7.4 Humedix
7.4.1 Humedix Company Information
7.4.2 Humedix Introduction and Business Overview
7.4.3 Humedix Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Humedix Salmon PDRN API Product Offerings
7.4.5 Humedix Recent Development
7.5 Ruijiming Biological
7.5.1 Ruijiming Biological Company Information
7.5.2 Ruijiming Biological Introduction and Business Overview
7.5.3 Ruijiming Biological Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Ruijiming Biological Salmon PDRN API Product Offerings
7.5.5 Ruijiming Biological Recent Development
7.6 Bloomage Biotech
7.6.1 Bloomage Biotech Company Information
7.6.2 Bloomage Biotech Introduction and Business Overview
7.6.3 Bloomage Biotech Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Bloomage Biotech Salmon PDRN API Product Offerings
7.6.5 Bloomage Biotech Recent Development
7.7 HENGYU BIOPH
7.7.1 HENGYU BIOPH Company Information
7.7.2 HENGYU BIOPH Introduction and Business Overview
7.7.3 HENGYU BIOPH Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 HENGYU BIOPH Salmon PDRN API Product Offerings
7.7.5 HENGYU BIOPH Recent Development
7.8 Mastelli
7.8.1 Mastelli Company Information
7.8.2 Mastelli Introduction and Business Overview
7.8.3 Mastelli Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Mastelli Salmon PDRN API Product Offerings
7.8.5 Mastelli Recent Development
7.9 Dongkook
7.9.1 Dongkook Company Information
7.9.2 Dongkook Introduction and Business Overview
7.9.3 Dongkook Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Dongkook Salmon PDRN API Product Offerings
7.9.5 Dongkook Recent Development
7.10 BR PHARM
7.10.1 BR PHARM Company Information
7.10.2 BR PHARM Introduction and Business Overview
7.10.3 BR PHARM Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 BR PHARM Salmon PDRN API Product Offerings
7.10.5 BR PHARM Recent Development
7.11 BNC Global
7.11.1 BNC Global Company Information
7.11.2 BNC Global Introduction and Business Overview
7.11.3 BNC Global Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 BNC Global Salmon PDRN API Product Offerings
7.11.5 BNC Global Recent Development
7.12 BMI KOREA
7.12.1 BMI KOREA Company Information
7.12.2 BMI KOREA Introduction and Business Overview
7.12.3 BMI KOREA Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 BMI KOREA Salmon PDRN API Product Offerings
7.12.5 BMI KOREA Recent Development
7.13 BNF Solution
7.13.1 BNF Solution Company Information
7.13.2 BNF Solution Introduction and Business Overview
7.13.3 BNF Solution Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 BNF Solution Salmon PDRN API Product Offerings
7.13.5 BNF Solution Recent Development
7.14 Nanjing Letop Biotechnology
7.14.1 Nanjing Letop Biotechnology Company Information
7.14.2 Nanjing Letop Biotechnology Introduction and Business Overview
7.14.3 Nanjing Letop Biotechnology Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Nanjing Letop Biotechnology Salmon PDRN API Product Offerings
7.14.5 Nanjing Letop Biotechnology Recent Development
7.15 Topscience Biotech
7.15.1 Topscience Biotech Company Information
7.15.2 Topscience Biotech Introduction and Business Overview
7.15.3 Topscience Biotech Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Topscience Biotech Salmon PDRN API Product Offerings
7.15.5 Topscience Biotech Recent Development
7.16 Freda Biotechnology
7.16.1 Freda Biotechnology Company Information
7.16.2 Freda Biotechnology Introduction and Business Overview
7.16.3 Freda Biotechnology Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Freda Biotechnology Salmon PDRN API Product Offerings
7.16.5 Freda Biotechnology Recent Development
7.17 Shebah Biotech
7.17.1 Shebah Biotech Company Information
7.17.2 Shebah Biotech Introduction and Business Overview
7.17.3 Shebah Biotech Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Shebah Biotech Salmon PDRN API Product Offerings
7.17.5 Shebah Biotech Recent Development
7.18 APR Corporation
7.18.1 APR Corporation Company Information
7.18.2 APR Corporation Introduction and Business Overview
7.18.3 APR Corporation Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 APR Corporation Salmon PDRN API Product Offerings
7.18.5 APR Corporation Recent Development
7.19 Kolmar Korea
7.19.1 Kolmar Korea Company Information
7.19.2 Kolmar Korea Introduction and Business Overview
7.19.3 Kolmar Korea Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Kolmar Korea Salmon PDRN API Product Offerings
7.19.5 Kolmar Korea Recent Development
7.20 PORIBIO INC.
7.20.1 PORIBIO INC. Company Information
7.20.2 PORIBIO INC. Introduction and Business Overview
7.20.3 PORIBIO INC. Salmon PDRN API Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 PORIBIO INC. Salmon PDRN API Product Offerings
7.20.5 PORIBIO INC. Recent Development
8 Industry Chain Analysis
8.1 Salmon PDRN API Industrial Chain
8.2 Salmon PDRN API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Salmon PDRN API Sales Model
8.5.2 Sales Channel
8.5.3 Salmon PDRN API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Salmon PDRN API market size was US$ 100 million in 2025 and is forecast to reach a readjusted size of US$ 698 million by 2032 with a CAGR of 32.5% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 103
USD 4250.00
(Single User License)
The global market for Salmon PDRN API was estimated to be worth US$ 100 million in 2025 and is projected to reach US$ 698 million, growing at a CAGR of 32.5% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 136
USD 3950.00
(Single User License)
The global Salmon PDRN API market was valued at US$ 100 million in 2025 and is anticipated to reach US$ 698 million by 2032, at a CAGR of 32.5% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 147
USD 2900.00
(Single User License)
The global Salmon PDRN API market is projected to grow from US$ 72.1 million in 2024 to US$ 540 million by 2031, at a CAGR of 32.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 171
USD 4900.00
(Single User License)
The global Salmon PDRN API market size was US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 102
USD 4250.00
(Single User License)
The global market for Salmon PDRN API was valued at US$ 72.1 million in the year 2024 and is projected to reach a revised size of US$ 540 million by 2031, growing at a CAGR of 32.5% during the forecast period.
Published Date: 2025-07-27
Pages: 113
USD 2900.00
(Single User License)
The global market for Salmon PDRN API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 86
USD 3950.00
(Single User License)
The global Salmon PDRN API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-07
Pages: 89
USD 2900.00
(Single User License)
The global Salmon PDRN API market size was US$ 100 million in 2025 and is forecast to reach a readjusted size of US$ 698 million by 2032 with a CAGR of 32.5% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 103
The global market for Salmon PDRN API was estimated to be worth US$ 100 million in 2025 and is projected to reach US$ 698 million, growing at a CAGR of 32.5% from 2026 to 2032.
Published: 2026-03-06
Pages: 136
The global Salmon PDRN API market was valued at US$ 100 million in 2025 and is anticipated to reach US$ 698 million by 2032, at a CAGR of 32.5% from 2026 to 2032.
Published: 2026-03-06
Pages: 147
The global Salmon PDRN API market is projected to grow from US$ 72.1 million in 2024 to US$ 540 million by 2031, at a CAGR of 32.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 171
The global Salmon PDRN API market size was US$ 72.1 million in 2024 and is forecast to a readjusted size of US$ 540 million by 2031 with a CAGR of 32.5% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 102
The global market for Salmon PDRN API was valued at US$ 72.1 million in the year 2024 and is projected to reach a revised size of US$ 540 million by 2031, growing at a CAGR of 32.5% during the forecast period.
Published: 2025-07-27
Pages: 113
The global market for Salmon PDRN API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 86
The global Salmon PDRN API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-07
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now